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212 Impact of enteral tube feeding on body fat and lean body mass
H. White1, A. Morton2, D. Peckham2. 1Leeds Metropolitan University, Leeds,
United Kingdom; 2Adult Cystic Fibrosis Unit, Leeds, United Kingdom
Objectives: Enteral tube feeding (ETF) has known beneﬁts, improving weight and
stabilising lung function in adult patients with CF. The aim of this study was to
examine how weight gain is achieved through measurement of fat deposition before
and after initiation of ETF.
Methods: 6 patients fulﬁlled the study criteria, having undergone measurement
of body composition [DEXA] 1 year prior to staring ETF and up to 18 months
post ETF. Percentage change in weight (kg), body fat (%), lean body mass (kg),
gynoid fat (%) and android fat (%) were recorded.
Results: 6 patients [3M/3F], aged 17.7–33.0 years were eligible to participate.
Body mass index at start ETF was 14.7–24.8 kg/m2. Fat deposition in the year after
enteral feeding achieved up to 340% increase. Android (central fat) deposition was
consistently greater than gynoid fat. 50% of cases had a reduction in lean body
mass after start of enteral tube feeding, despite only one case displaying weight
loss over this period.
Table 1
Case Weight change %fat % android fat % gynoid fat % lean body mass
with ETF pre/post
ETF
%
change
pre/post
ETF
Change pre/post
ETF
Change pre/post
ETF
Change
1 31.7% 7.30/10.0 37% 7.70/12.10 57% 12.60/16.90 15.9% 35.60/45.40 27.5%
2 1.9% 10.2/15.5 50.1% 12.8/19.10 49.2% 18.20/26.00 43% 41.50/39.00 −6%
3 −12.8% 34.40/32.10 −6.6% 39.40/33.70 −14.5% 44.80/44.90 0 34.80/31.60 −9.2%
4 17.4% 21.00/30.00 42.8% 16.80/30.10 79.2% 38.30/48.00 25% 33.00/34.70 5.1%
5 8.2% 24.20/35.3 45.9% 26.70/38.30 43.4% 36.90/40.90 10.8% 37.30/33.70 −9.7%
6 35.5% 6.20/27.30 340% 5.30/29.10 449% 10.60/38.70 265% 46.50/48.60 4.5%
Conclusion: In a case series of adults with CF, ETF resulted in 37–340% gain
in body fat in all 5 of 6 patients who gained weight. This was predominantly as
android fat, a predictor of Type 2 diabetes in the general population. ETF is a
known risk factor for cystic ﬁbrosis related diabetes and prompts further evaluation
of nutritional practice in CF.
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Objectives: In CF pregnant women, weight gain is essential for foetal growth and
for maintaining maternal health. Diabetes is also associated with poorer prognosis.
Optimizing nutrition and diabetes care in CF pregnant patients requires careful
dietary monitoring. The aim of our study was to evaluate the dietary management
of CF during pregnancy.
Methods: We reviewed the medical and dietary records from 30 patients cared at
our adult CF centre during pregnancy between 2008 and 2013.
Results: Before pregnancy, median age was 28.5 years (range, 20−38), mean BMI
20.4±2.6 kg/m2, mean FEV1 61±15% pred. 23 (77%) patients had pancreatic
insufﬁciency and 10 (33%) had diabetes. Two more patients developed gestational
diabetes. The mean number of dietician visits during pregnancy was 2.5 (0−6).
During initial assessment, speciﬁc issues regarding quantitative and qualitative
nutritional needs during pregnancy were addressed. At each visit, solutions were
proposed in case of difﬁculties (poor appetite, nausea, vomiting, and weight loss),
vitamin and mineral (calcium, iron) deﬁciencies were corrected, and diabetes was
monitored. We recommended splitting food (3 meals/d + snacks) and enrichment
with common food (e.g., butter, milk powder). 14 patients (53%) received oral
nutritional supplements and 3 had enteral nutrition. All patients gained weight
(mean 7.2±4.2 kg) during pregnancy. After delivery, 7 patients had lost weight
compared to the previous year. Mean birth weight was 2999±490 g. The mean
gestational age at delivery was 38.1±1.9 weeks.
Conclusion: The dietician should assess and counsel women at the CF centre to
achieve optimal nutritional status throughout pregnancy.
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Objectives: More women with CF are expected to become pregnant, due to their
increased survival and to advances in Assisted Reproductive Technology (ART).
We compared the maternal and perinatal outcomes of pregnancies in women with
CF and women in the general population.
Methods: In this retrospective case–control study, CF women cared at our adult CF
centre who delivered in our maternity ward from December 2000 to December 2013
were matched each to two controls. The primary endpoint was the median term of
delivery and secondary endpoints were the maternal and perinatal outcomes.
Results: 33 pregnancies in 30 women with CF were compared to 66 pregnancies in
controls (median age 28.8 vs 32.1 years; p< 0.003). The median term of delivery
was similar in the two groups (38.1±1.6 WG vs 38.4±1.1 WG; p = 0.28). ART
pregnancies were more frequent in CF women (51% vs 3%, p< 0.003). In CF
women, the initial BMI was lower (19.5 vs 22.4 kg/m2; p = 0.001) and pre-existing
diabetes was more frequent (30% vs 3%; p< 0.001). Those differences persisted
during pregnancy for weight gain (9.1±7.1 kg vs 13.2±6.4 kg; p< 0.001), gain of
more than 10 kg (36% vs 65%; p = 0.009) and diabetes (51% vs 8%; p< 0.001).
Spontaneous labour and spontaneous vaginal deliveries were less frequent in CF
than in controls (respectively 45% vs 70%, p = 0.002; 51% vs 70%, p = 0.11). There
was an equal number of caesarean sections (24% vs 22%; p = 0.80). Foetal outcome
was similar in both groups, including birth weight (3042±91 g vs 3119±92 g,
p = 0.30).
Conclusion: Multidisciplinary care of pregnancy in women with CF resulted
in maternal and perinatal outcomes similar to those of women in the general
population.
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Objectives: Hand grip strength (HGS), as an assessment of peripheral muscle
function, has been used as a surrogate marker for nutritional status in conditions
where body mass index (BMI) is unreliable due to changes in ﬂuid status (such
as renal and liver disease). Reduced HGS has been shown to predict post-
operative complications in surgical patients (Klidjian, 1982). Since its utility in
CF management has not been examined, we set out to determine whether HGS
might correlate with disease severity in an adult CF cohort.
Methods: We performed HGS in 201 sequential CF patients attending for annual
review at Papworth Hospital, UK. HGS, measured using a standardised protocol,
was compared to clinical features (age, gender, BMI and FEV1% predicted) and a
marker of overall disease severity (the UK CF Trust banding status where band 1
is a the least severe and band 5 the most severe disease).
Results:Mean HGS values obtained for adults with CF were signiﬁcantly lower than
age-matched healthy reference values. HGS reference values for healthy individuals
ranged from 18.9–46.1 kg (females) and 22.9–68.7 kg (males). Mean HGS values
obtained in this study were 22.0±5.27 kg for females and 36.5±9.68 kg for males.
63% of female and 44% of male CF patients had HGS <85% of normal reference
values. When stratiﬁed for clinical disease severity there was a signiﬁcant difference
in HGS between the most severe and least severe groups (p = 0.04).
Conclusion: HGS in CF adults is signiﬁcantly reduced compared to healthy
reference values and declines with worsening clinical status. HGS may be a useful
additional test to assess nutritional status and disease severity.
